WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

New stock news | Jia Zhi Technology submits application to Hong Kong Stock Exchange as one of the top ten global intelligent mobile robot and automation company Siasun Robot & Automation.

New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange

New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.
New stock news | Jia Zhi Technology submits application to Hong Kong Stock Exchange as one of the top ten global intelligent mobile robot and automation company Siasun Robot & Automation.

New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange

New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


